Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Net Margin: 2010-2018

Historic Net Margin for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Sep 2018 value amounting to -2,956.58%.

  • EyePoint Pharmaceuticals' Net Margin fell 139658.00% to -2,956.58% in Q3 2018 from the same period last year, while for Sep 2018 it was -1,553.93%, marking a year-over-year decrease of 132731.00%. This contributed to the annual value of -1,795.71% for FY2018, which is 155052.00% down from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Net Margin of -2,956.58% as of Q3 2018, which was down 116.11% from -1,368.11% recorded in Q2 2018.
  • EyePoint Pharmaceuticals' 5-year Net Margin high stood at 81.27% for Q3 2014, and its period low was -5,808.00% during Q4 2017.
  • Moreover, its 3-year median value for Net Margin was -1,555.86% (2016), whereas its average is -1,834.91%.
  • Data for EyePoint Pharmaceuticals' Net Margin shows a peak YoY increase of 122,852bps (in 2017) and a maximum YoY decrease of 580,688bps (in 2017) over the last 5 years.
  • EyePoint Pharmaceuticals' Net Margin (Quarterly) stood at -782.15% in 2014, then slumped by 20,378bps to -985.93% in 2015, then soared by 98,481bps to -1.12% in 2016, then slumped by 580,688bps to -5,808.00% in 2017, then tumbled by 139,658bps to -2,956.58% in 2018.
  • Its Net Margin stands at -2,956.58% for Q3 2018, versus -1,368.11% for Q2 2018 and -504.09% for Q1 2018.